Lumida
/GOCO
⌘K
Gohealth Inc

Gohealth Inc

GOCO
$0.35USD-1.14%-0.00 today

MARKET CAP

10.3M

P/E (TTM)

FWD P/E

DAY RANGE

$0 – $0

52W RANGE

$0
$0

AI Summary

Stalk
Sell NowHigh

GOCO remains in a Stage 4 decline with persistent lower highs and lower lows under declining EMAs. Relief rallies into the 9/20/50EMA and 50DMA quickly reject, and volume clusters on down moves confirm supply dominance. Short-term trend is down, with no exhaustion visible, making selling now into any bounce the optimal execution posture.

  • Launched GoHealth Protect, offering guaranteed-acceptance life insurance for diversification.
  • Q4’24 revenue $389M (+41% YoY) and adjusted EBITDA $118M (+107% YoY).
  • Q3’25 revenue fell 10% due to intentional Medicare Advantage pullback.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

GoHealth, Inc. (NASDAQ: GOCO) operates within the healthcare technology sector, primarily facilitating consumer access to Medicare-related insurance products and services. With unique technological tools, GoHealth guides Medicare beneficiaries through the complex landscape of various plan options, leveraging its digital capabilities to enhance user engagement. Positioned amid an evolving Medicare environment, GoHealth has aimed to maintain leadership in the Medicare Advantage market, amidst recent strategic pivots towards prioritizing retention and enhanced consumer experience.

Bull says

  • Launched GoHealth Protect, offering guaranteed-acceptance life insurance for diversification.
  • Q4’24 revenue $389M (+41% YoY) and adjusted EBITDA $118M (+107% YoY).
  • Reduced CAC by 27% YoY to $501 per submission.
  • Secured $115M term loan, alleviating liquidity and lender concerns.
  • Submission volumes rose 67% YoY to 481K in Q4’24.
  • Management expects Medicare Advantage enrollment stabilization post-market rationalization.

Bear says

  • Q3’25 revenue fell 10% due to intentional Medicare Advantage pullback.
  • Operating cash flow negative $12.4M, straining financial flexibility.
  • Annual Enrollment Period uncertainty may disrupt enrollment and revenue.
  • DOJ False Claims Act probe risks legal costs and distractions.
  • Retention-first strategy may sacrifice near-term volume growth.
  • High dependence on Medicare Advantage dynamics increases performance variability.

Investment themes with GOCO

Health Insurers (MCOs) +0.24%

UNH · CVS · CI

Earnings Call · Q3 2024 · Mgmt. Guidance

Updated 06-29-2026neutral

Transcript signals

Bull points

  • In the third quarter of 2024, Go Health achieved net revenues of $118.3 million, compared to $132 million in the same period last year. Internal captive agent submissions saw a 46% year-over-year increase, thanks to enhanced training, improved technology, and more targeted marketing efforts.
  • Third quarter 2024 trailing 12 months, or TTM, had a positive cash flow from operations of $35.1 million, an increase of $38.3 million, compared to the TTM negative cash flow from operations of $3.2 million in the prior year period.
  • We are deploying cash to seize the significant opportunities ahead, which we believe will position us to maximize growth and capitalize on the outsized potential we see in the current environment.

Bear points

  • 46% decline in submissions from our GPS channel, which faced broader market pressures.
  • reduction in third quarter revenue of over $8.8 million and earnings by more than $7.8 million.
  • negative $12.1 million, a slight decrease of $600,000 compared to the prior year.
Read full transcript analysis ›